Werkgroep personeel / HNW-kantooromgeving dinsdag 11 maart 2014 VAC Hasselt + verslag werkgroep
WERKGROEP HERSENTUMOREN vzw Study Group Brain Tumours
description
Transcript of WERKGROEP HERSENTUMOREN vzw Study Group Brain Tumours
Dia 1
WERKGROEP HERSENTUMOREN vzwStudy Group Brain TumoursRECENT ADVANCES IN THE BRAIN IMAGINGA PATIENTS OPINION16.03.2010European Parliament, Brussels
WERKGROEP HERSENTUMOREN VZWStudy Group Brain TumoursBrain TumoursIncidence HG BT 8 new cases/100.000 people/yearIncidence LG BT 8 new cases/100.000 people/yearSource: Improving Outcomes for People with Brain and other CNS Tumours; National institute for Health and Clinical Excellence, June 2006In Europe80.000 new cases/year
Typical Stages of the DiseaseVague SymptomsHeavy Neurological SymptomsDiagnosisDetailed DiagnosisNeurosurgeryRadiotherapy if HGChemotherapy if HGRehabilitationAdaptation-IntegrationFollow Up ACUTE PHASE
TREATMENT
REHABILITATION
DIAGNOSIS=LOOKING INSIDE THE SKULL
LOOKING INSIDE THE SKULL2 METHODSCT-SCAN
Work with X-raysIonising effectsMay cause cancer (certainty) Lower resolutionMRI-SCAN
-Work with magnetical resonance-Raise of temperature of 0,1 C-No known lasting effects-No evidence for cancer-Higher resolution
DETAILED DIAGNOSISPrimary or secundary brain tumour ?Exact locationFunctional analysis (PET-SCAN)EEGStereotactical biopsy
NEUROSURGERYStereotactical frameMappingAwake surgeryNeurostimulationInterventional MRI
FOLLOW UPRegular Controls with MRI
CONCLUSIONSDiagnosis, treatment and follow up depend entirely on the MRI technologyMRI is a less harmful tool than CTQuality of images are superior with MRI